Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Biogaia Adr Class B BIOGY

Healthcare Biotechnology
Biogaia AB is a Sweden-based healthcare company that is engaged in the development and sell of probiotic products. The Company develops, markets and sells probiotic products with documented health benefits. The products are primarily based on different strains of the lactic acid bacterium Limosilactobacillus reuteri. The Company’s activities are divided into three segments: The Paediatrics... see more

Recent & Breaking News (PINL:BIOGY)

ARMGO Pharma and Servier Announce Advancement of Rycal ARM210/S48168 into Clinical Stage Program Targeting Duchenne Muscular Dystrophy

PR Newswire December 4, 2014

Kalorama: Robot-Assisted PCR Among Innovations Driving Market

PR Newswire December 4, 2014

ContraFect Corporation to Present at the Oppenheimer 25th Annual Healthcare Conference

Marketwired December 4, 2014

Human Microbiome Market: Biomedical Implications and Commercial Research Report

PR Newswire December 4, 2014

TetraLogic Pharmaceuticals Announces Clinical Data on Birinapant to be Presented at the 56th Annual American Society of Hematology Annual Meeting

GlobeNewswire December 4, 2014

First And Only Treatment for Multicentric Castleman's Disease, SYLVANT(TM), Now Approved in Canada

Canada NewsWire December 4, 2014

Sigma-Aldrich Life Sciences Licenses Foundational CRISPR Patents from Broad Institute

PR Newswire December 4, 2014

ADARA Delivers SDN WAN Optimization, Services Choreography and Network Orchestration as part of the HP Networking SDN Ecosystem

PR Newswire December 4, 2014

MEI Pharma Announces Election of Pharmaceutical Industry Veteran Kevan Clemens to Board of Directors

PR Newswire December 4, 2014

Creating a Legacy of Hope with RevitaLash® Cosmetics

PR Newswire December 4, 2014

Applied DNA Sciences Signs With Fourth Federal Agency

Marketwired December 4, 2014

Pluristem and Hadassah Medical Center Will Collaborate to Study Potential of PLX-RAD Cells to Improve Bone Marrow and Umbilical Cord Blood Transplant Outcomes

GlobeNewswire December 4, 2014

Genmab Announces Phase II Study of Daratumumab in Non-Hodgkin's Lymphomas

GlobeNewswire December 4, 2014

Avera Health partners with Elekta to deliver most advanced cancer care

PR Newswire December 4, 2014

Leica Biosystems to Acquire Devicor Medical Products, Inc.

Canada NewsWire December 4, 2014

DNA Sequencing Breakthrough -- Ex-Groupon CEO Joins Prenetics, Launches Non-Invasive Prenatal Test in Hong Kong

Marketwired December 3, 2014

Cryo-Cell Adopts Three-Year Stockholder Rights Plan

GlobeNewswire December 3, 2014

Cancer Genetics Inc. Announces the Appointments of Dr. Howard McLeod and Geoffrey Harris to Its Board of Directors

GlobeNewswire December 3, 2014

Minister Ambrose takes part in Canadian Blood Services' 'Wrap It Up Red' Campaign

Canada NewsWire December 3, 2014

Aduro Biotech Announces Preclinical Data Presented at American Association for Cancer Research Tumor Immunology and Immunotherapy Conference

Business Wire December 3, 2014